How a Tiny Pill Is Taking On One of the Deadliest Cancers

Scientists have identified a key vulnerability in pancreatic cancer by targeting transcription-replication conflicts—cellular disruptions that cause genetic instability in tumors. Their novel approach uses a drug called AOH1996, which slowed tumor growth in lab models and reduced tumors in human patients, showing promise where traditional treatments have failed. This breakthrough offers hope for fighting one […] Read More